Brain accumulation of the EML4-ALK inhibitor ceritinib is restricted by P-glycoprotein (P-GP/ABCB1) and breast cancer resistance protein (BCRP/ABCG2)

Anita Kort, Rolf W. Sparidans, Els Wagenaar, Jos H. Beijnen, Alfred H. Schinkel

Pharmacological Research · 2015 · 70 citations · 32 references

DOIFull text

Open access

Concepts

References

32